By Lynne V. McFarland (auth.), Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz (eds.)
In Biotherapeutic brokers and Infectious ailments, top investigators energetic within the discovery, improvement, and alertness of this novel classification of anti-infective brokers concisely assessment using those specified microorganisms in treating human disorder. targeting biotherapeutic entities which have been confirmed in managed reports, the famous specialists light up the clinical underpinnings in their healing power, check their attainable hazards within the remedy of infectious illnesses, and description the examine had to greater outline their effectiveness. moreover, additionally they contemplate biotherapeutic brokers might be genetically engineered for optimum intestinal and vaginal construction of bioactive elements in vivo.
Biotherapeutic brokers and Infectious illnesses brings jointly the entire facts had to comprehend and capitalize at the substantial promise of this crucial new category of biotherapeutic entities. instead to antibiotics that more and more result in drug-resistant pathogens, the residing microorganisms defined during this well timed and authoritative e-book will considerably reduction trendy clinicians within the prevention and remedy of infectious illnesses.
Read or Download Biotherapeutic Agents and Infectious Diseases PDF
Best diseases books
What law we could have for the operation? Shall a guy transfuse he understands now not what. to right he understands now not what. God is familiar with how (l)? Dr. Henry Stubbs Royal university of Physicians circa 1670 If dialysis remedy have been a brand new phannaceutical product being evaluated by way of the FDA now, it will probably now not be licensed for advertising.
- Control of Chagas Disease: 2nd Report of the WHO Expert Committee on Chagas Disease (Technical Report Series)
- Niere und ableitende Harnwege
- A Multidisciplinary Approach to Myelin Diseases II
- A Clinical Guide to Inherited Metabolic Diseases (2nd Edition)
- Cellular Peptidases in Immune Functions and Diseases
Additional info for Biotherapeutic Agents and Infectious Diseases
Colombel, J. , et a1. (1988) Bacterial translocation in patients with colorectal cancer. J. Infect. Dis. 158, 1395, 1396. 41. , and Rambaud, J. C (1986) Influence de Saccharomyces boulardii sur la secretion jejunale induite chez le rat par la toxine cholerique. Gastroenterol. Clin. Biol. 10, 13-16. 42. , and Rampal, P. (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5' -cyclic monophosphate induction in intestinal cells. Gastroenterology 106, 65-72. 43. Delmee, M. and Buts, J.
R, Gorbach, S. , and Salminen, S. (1992) Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sei. 37, 121-128. 12. , Gustafsson, J. , and Nord, C. E. (1987) Impact of Lactobaeillus aeidophilus supplements on the human oropharyngeal and intestinal microflora. Seand. J. Infeet. Dis. 19,531-537. 42 Buts 13. , and Rambaud, J. C. (1992) Feeal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 102, 875-878. 14. , Jacobus, N.
Jacobus, N. , and Gorbach, S. L. (1987) Antimicrobial substance from a human Lactobacillus strain. Antirnierob. Agents Chemother. 31, 1231-1233. 24 McFarland 7. , and Petitdemange, H. (1990) Screening of Bifidobacterium strains from bacteriocin production. Bioteehnol. Lett. 12,575-580. 8. Brugier, S. and Patte, E (1975) Antagonismes in vitro entre l'ultralevure et differents germes bacteriens. Med. Paris 45, 3-8. 9. Meurman, J. , Korhonen, A, and Salminen, S. (1995) Effect of Lactobaeillus rhamnosus strain GG (ATCC 53103) on the growth of Streptoeoceus sobrinus in vitro.
Biotherapeutic Agents and Infectious Diseases by Lynne V. McFarland (auth.), Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz (eds.)